Luca Di Noto
Directeur Technique/Scientifique/R&D chez JASPER THERAPEUTICS, INC.
Profil
Luca Di Noto is currently working as the Vice President-Technical Operations at Jasper Therapeutics, Inc. Prior to this, he worked at Portola Pharmaceuticals LLC as the Head-Drug Substance Manufacturing from 2015 to 2020.
Postes actifs de Luca Di Noto
| Sociétés | Poste | Début |
|---|---|---|
| JASPER THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Anciens postes connus de Luca Di Noto
| Sociétés | Poste | Fin |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| Entreprise privées | 1 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
